BloodReady™ Webinar | Beating the Clock: Whole-Blood Processing | 22 Sept 2026

Date: Tuesday, 22 September 2026  |  Time: 15: 00 CET

Join Atelerix for a webinar on overcoming the major challenges of time-sensitive whole-blood sample handling. Discover BloodReady™ – an innovative hydrogel encapsulation solution that preserves viable leukocytes in whole blood, enabling refrigerated transport and recovery at a central laboratory without fixation or on-site PBMC isolation.

Overview

Whole-blood samples are highly time-sensitive, yet many research and clinical workflows depend on transporting samples from dispersed collection sites to central laboratories. Short processing windows can lead to sample degradation, compromised data quality and costly logistical challenges. Current approaches each present limitations. Fresh blood requires rapid processing and specialist capabilities at the collection site. Fixation can alter epitopes and removes the option for live-cell analysis, while PBMC isolation and cryopreservation introduce additional processing, variability and potential cell loss.

This webinar will explore these practical and scientific challenges before introducing BloodReady™ - an alternative approach for preserving viable leukocytes within whole blood. BloodReady enables samples to be transported at 2-8°C and recovered at a central laboratory, without fixation or on-site PBMC isolation and cryopreservation. Attendees will learn how this approach can extend the whole-blood processing window, simplify sample logistics, support more flexible collection networks and enable standardised downstream immunophenotyping and PBMC workflows.

BloodReady™ uses Atelerix’s proprietary hydrogel encapsulation technology. Simply mix the whole-blood sample with a Gel A solution and transfer it to a tube preloaded with BloodReady™ beads. After a brief gelation step at room temperature, the encapsulated sample is stored at 2–8°C for up to three days. When ready for use, a gentle Dissolution Buffer is added to release the sample, and the beads are filtered out. The recovered blood retains key leukocyte populations and cell surface markers, ready for high-quality downstream applications including immunophenotyping, PBMC isolation, and functional assays. Available for blood volumes of 0.5 mL, 1 mL, 3 mL, 5 mL and 10 mL (larger volumes on request).

Target Audience

This webinar is intended for professionals involved in the collection, transportation, processing or analysis of whole-blood samples, including:

• Clinical research organisations and central laboratories
• Pharmaceutical and biotechnology companies
• Clinical trial and biomarker teams
• Flow cytometry and immunophenotyping laboratories
• Cell and gene therapy researchers
• Translational and immunology researchers
• Biobanks and biospecimen providers
• Laboratory, sample-logistics and clinical operations teams

Why BloodReady™?

BloodReady™ is designed for the encapsulation of whole blood in a simple, scalable vial format. It enables the preservation and transport of whole blood at refrigerated temperatures while maintaining immune cell viability and function. Key benefits include:

• Preservation of whole blood samples for up to 3 days at 2–8°C
• Retention of all major leukocyte populations and cellular markers without fixation or cryopreservation
• >95% viability of whole blood leukocytes after 3 days (compared with significantly lower viability using standard storage or cryopreservation)
• Better conservation of unstable surface epitopes than common fixation methods
• Compatibility with immunophenotyping, PBMC isolation, clinical diagnostics and biopharmaceutical research
• Pharmaceutical-grade & GMP-sourced components; each batch QC-tested; ISO 9001: 2015 accredited manufacturing

The recovered blood is ready for high-quality downstream applications, supporting standardised workflows across dispersed collection sites and central laboratories.